4/A
Changes in Ownership
GALECTIN THERAPEUTICS INC Filed Acc 0001493152-25-026587
10% owner sold 162,069 shares at an average $5.68 ($920,855)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 10X Fund, L.P. 10% owner | 2025-12-02 | Sale | −30,000 | $5.47 | $164,100 | 5,802,207 | D: show line 1 in the form |
| 10X Fund, L.P. 10% owner | 2025-12-03 | Sale | −132,069 | $5.73 | $756,755 | 5,670,138 | D: show line 2 in the form |
| Open-market sales · 162,069 sh · avg $5.68 · $920,855 | |||||||
Loading xslF345X05/ownership.xml…